BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25279812)

  • 1. Breast cancer risk in MEN1 - a cancer genetics perspective.
    Brennan P
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):327-229. PubMed ID: 25279812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands.
    Seigne C; Auret M; Treilleux I; Bonnavion R; Assade F; Carreira C; Goddard-Léon S; Lavergne E; Chabaud S; Garcia A; Mazoyer S; Lu J; Bachelot T; Frappart L; Zhang CX
    J Pathol; 2013 Mar; 229(4):546-58. PubMed ID: 23180448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group.
    van Leeuwaarde RS; Dreijerink KM; Ausems MG; Beijers HJ; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Peeters PHM; Pijnappel RM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2083-2090. PubMed ID: 28323962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
    Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
    Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to: Breast cancer risk in MEN1--a cancer genetics perspective.
    Dreijerink KM; Valk GD
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):141. PubMed ID: 25409873
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
    Shimazu S; Nagamura Y; Yaguchi H; Ohkura N; Tsukada T
    Cancer Sci; 2011 Nov; 102(11):2097-102. PubMed ID: 21819486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
    Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
    Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menin molecular interactions: insights into normal functions and tumorigenesis.
    Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
    Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
    Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
    Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Murat A; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Parfait B; Chabre O; Castermans E; Beckers A; Ruszniewski P; Le Bras M; Delemer B; Bouchard P; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Penfornis A; Bihan H; Archambeaud F; Kerlan V; Duron F; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Hum Mol Genet; 2013 May; 22(10):1940-8. PubMed ID: 23376981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 1: a chromatin writer's block.
    Dreijerink KM; Lips CJ; Timmers HT
    J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN1 gene and its mutations: basic and clinical implications.
    Tsukada T; Nagamura Y; Ohkura N
    Cancer Sci; 2009 Feb; 100(2):209-15. PubMed ID: 19068082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response.
    Busygina V; Kottemann MC; Scott KL; Plon SE; Bale AE
    Cancer Res; 2006 Sep; 66(17):8397-403. PubMed ID: 16951149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
    Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
    Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
    Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
    Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
    Papi L; Palli D; Masi L; Putignano AL; Congregati C; Zanna I; Marini F; Giusti F; Luzi E; Tonelli F; Genuardi M; Brandi ML; Falchetti A
    Cancer Genet Cytogenet; 2009 Nov; 195(1):75-9. PubMed ID: 19837273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.